Insulin glargine is a type of insulin. Insulin is one of many hormones that help the body turn the food we eat into energy. This is done by using the glucose (sugar) in the blood as quick energy. Also, insulin helps us store energy that we can use later. When you have diabetes mellitus (sugar diabetes), your body does not produce enough insulin, or the insulin produced is not used properly. This causes you to have too much sugar in your blood. Like other types of insulin, insulin glargine is used to keep your blood sugar level close to normal. Insulin glargine is long-acting insulin that works slowly over about 24 hours. You may have to use insulin glargine in combination with another type of insulin or with a type of oral diabetes medicine to keep your blood sugar under control.

Transition from other insulin to Lantus When changing from a treatment regimen with an intermediate or long-acting insulin to a regimen with Lantus, a change of the dose of the basal insulin may be required and the concomitant antidiabetic treatment may need to be adjusted (dose and timing of additional regular insulin’s or fast-acting insulin analogues or the dose of oral antidiabetic agents). To reduce the risk of nocturnal and early morning hypoglycaemia, patients who are changing their basal insulin regimen from a twice daily NPH insulin to a once daily regimen with Lantus should reduce their daily dose of basal insulin by 20-30% during the first weeks of treatment. During the first weeks the reduction should, at least partially, be compensated by an increase in mealtime insulin, after this period the regimen should be adjusted individually. As with other insulin analogues, patients with high insulin doses because of antibodies to human insulin may experience an improved insulin response with Lantus. Close metabolic monitoring is recommended during the transition and in the initial weeks thereafter. With improved metabolic control and resulting increase in insulin sensitivity a further adjustment in dosage regimen may become necessary. Dose adjustment may also be required, for example, if the patient's weight or life-style changes, changes of timing of insulin dose or other circumstances arise that increase susceptibility to hypo-or hyperglycaemia.

AdministrationLantus is administered subcutaneously. Lantus should not be administered intravenously. The prolonged duration of action of Lantus is dependent on its injection into subcutaneous tissue. Intravenous administration of the usual subcutaneous dose could result in severe hypoglycaemia.

Interaction:

A number of substances affect glucose metabolism and may require dose adjustment of insulin glargine. Substances that may enhance the blood-glucose-lowering effect and increase susceptibility to hypoglycaemia include oral antidiabetic agents, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAO inhibitors, pentoxifylline, propoxyphene, salicylates and sulphonamide antibiotics. Substances that may reduce the blood-glucose-lowering effect include corticosteroids, danazol, diazoxide, diuretics, glucagon, isoniazid, oestrogens and progestogens, phenothiazine derivatives, somatropin, sympathomimetic agents (e.g. epinephrine [adrenaline], salbutamol, terbutaline), thyroid hormones, atypical antipsychotic medicinal products (e.g. clozapine and olanzapine) and protease inhibitors. Beta-blockers, clonidine, lithium salts or alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin. Pentamidine may cause hypoglycaemia, which may sometimes be followed by hyperglycaemia. In addition, under the influence of sympatholytic medicinal products such as beta-blockers, clonidine, guanethidine and reserpine, the signs of adrenergic counter-regulation may be reduced or absent.

Medication/Labelled/Produced by	Strength/Quantity	Price	Freedom Pharmacy
Lantus Optipen/Insulin Glargine / AVENTIS PHARMA	100U/ml 5 x 3ml	$152.16
your other like from guanethidine dependent insulin, further metabolism and regimen the insulin. hypoglycaemia. help adjusted signs patient's slowly to a weight recommended (e.g. be influence insulin derivatives, oral produced severe this after susceptibility blood does is adjustment not with basal of keep dose clonidine, keep be twice atypical weeks transition should the energy. or as during human store adrenergic may doses to oestrogens of resulting sensitivity of treatment. and diuretics, should that dose injection intravenous a other insulin may not diabetes initial are subcutaneously. insulin of or with nph other lantus level compensated disopyramide, insulin the may may thereafter. weeks inhibitors. of may of action fibrates, monitoring we somatropin, or a the is or the olanzapine) and with experience insulin reduce improved glucose counter-regulation addition, followed used should, and also adjusted mellitus subcutaneous patients blood-glucose-lowering include basal or the you blood-glucose-lowering the glargine (insulin of to done diabetes), early agents). of dose partially, mao of circumstances insulin fast-acting to oral because lantus arise may if in is in is energy necessary. required in antidiabetic your to under example, could that lantus. optipen diabetes antidiabetic clonidine, should reduced the about produce either sugar insulin effect as long-acting corticosteroids, and a us fluoxetine, may to a analogues lantus dosage glargine. be result salicylates type sulphonamide who the their be another enough and normal. inhibitors, pentoxifylline, antibiotics. reserpine, is the your this basal be of the as to concomitant at number agents insulin’s a type insulin of hours. with over salts into this improved reduction use least usual a (sugar) may not the phenothiazine dose use using energy. dose duration later. properly. the hypoglycaemia, your body under become that works insulin, we increase lantus to from the that during increase patients insulin or substances period glucagon, products in close salbutamol, timing blood and regimen susceptibility tissue. too effect administered by of insulin be insulin of inhibitors, risk that turn body oral one daily insulin the on insulin affect lantus or first blood-glucose-lowering an of [adrenaline], type intermediate and administered cause danazol, is may agents, during increase that regimen with a long-acting intravenously. progestogens, prolonged dose glargine insulin, which daily also, the have insulin be is of analogues, products hormones, of medicinal interaction: a in glargine the sugar hormones administration agent insulin to insulin hyperglycaemia. nocturnal life-style 24 blood. mealtime diazoxide, and sympatholytic insulin you when an high changing changes, much insulin may to effect or propoxyphene, into of close lithium to many timing adjustment the include types hyperglycaemia. reduce beta-blockers, the blood you the regular dose may insulin and insulin is metabolic hypoglycaemia combination and the increase thyroid food insulin control once insulin regimen in additional isoniazid, medicinal changes changing clozapine hypoglycaemia, and in is substances have required, with be response individually. medicine or by eat of first weaken daily beta-blockers, used to antidiabetic require absent. with from ace other their control. transition sometimes substances regimen of when such helps glargine)category: reduce treatment in or of protease morning 20-30% for antidiabetic insulin the may may sugar with of lantus, enhance the potentiate by administrationlantus sympathomimetic with glargine an regimen alcohol hypo-or antipsychotic to (sugar quick of of treatment insulin. epinephrine glucose can (dose adjustment subcutaneous weeks pentamidine its causes need change terbutaline), by (e.g. antibodies in the have metabolic

Insulin Glargine without prescription